| __timestamp | PTC Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 44820000 | 1802274 |
| Thursday, January 1, 2015 | 82080000 | 2512761 |
| Friday, January 1, 2016 | 97130000 | 2894488 |
| Sunday, January 1, 2017 | 121271000 | 8096274 |
| Monday, January 1, 2018 | 153548000 | 7985229 |
| Tuesday, January 1, 2019 | 202541000 | 8994597 |
| Wednesday, January 1, 2020 | 245164000 | 29772000 |
| Friday, January 1, 2021 | 285773000 | 33907000 |
| Saturday, January 1, 2022 | 325998000 | 26579000 |
| Sunday, January 1, 2023 | 332540000 | 49868547 |
In pursuit of knowledge
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustaining growth and innovation. Over the past decade, PTC Therapeutics, Inc. and Verona Pharma plc have demonstrated contrasting trajectories in their SG&A expenditures. From 2014 to 2023, PTC Therapeutics saw a staggering 642% increase in SG&A expenses, peaking at approximately $332 million in 2023. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Verona Pharma's SG&A expenses grew by 2,667% over the same period, reaching nearly $50 million in 2023. This sharp rise indicates a strategic shift towards scaling operations and enhancing market presence. These trends highlight the dynamic nature of financial strategies within the biopharma sector, where balancing operational costs with growth ambitions is key to long-term success.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc.